Actively Recruiting

Age: 18Years - 100Years
All Genders
NCT06884878

Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)

Led by National Cancer Institute, Naples · Updated on 2025-03-24

103

Participants Needed

1

Research Sites

107 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The INNOVA project aims to create an advanced multidisciplinary diagnostic platform to support the Italian healthcare system and translational research. In this context, WP7, coordinated by the Pascale Institute and the focus of this study protocol, is responsible for developing a national platform for the multi-omic profiling of cancer patients eligible for precision medicine treatments, with the goal of supporting clinical decision-making.

CONDITIONS

Official Title

Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Consent to participate in the study
  • Age greater than 18 years
  • Performance status 0-1
  • Availability of biological samples for multi-omic profiling
  • Availability of radiological images for radiomic assessments
  • Patients with metastatic disease, stage IV (except melanoma stage II/III eligible for adjuvant therapy)
  • Patients eligible for targeted therapy and/or immunotherapy
  • Patients with aggressive neoplasms such as melanoma, non-small cell lung carcinoma, colon carcinoma (BRAF-mutated, MSI), triple-negative breast cancer, ovarian cancer, and cholangiocarcinoma
Not Eligible

You will not qualify if you...

  • Previous line of immunotherapy or targeted therapy
  • Previous radiotherapy at the sites of the most recent diagnostic biopsy
  • Most recent diagnostic biopsy performed more than 24 months before enrollment
  • Absence of measurable lesions
  • Presence of active or untreated brain metastases or leptomeningeal carcinomatosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale

Naples, Italy, 80131

Actively Recruiting

Loading map...

Research Team

A

Antonella De Luca

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here